Swelling of Penicillium digitatum conidia by a Fusarium acuminatum NRRL 6227 metabolite

Mycopathologia
|November 30, 1977
PubMed

Insights

Fusarium acuminatum produces an antifungal cyclic peptide that swells and kills Penicillium conidia. This novel antibiotic disrupts fungal growth by targeting spore viability.

Area of Science:

  • Mycology
  • Biochemistry
  • Antimicrobial Research

Background:

  • Fungal infections pose significant threats to agriculture and human health.
  • Developing novel antifungal agents is crucial for combating resistant fungal strains.
  • Fusarium acuminatum is a known fungal species with potential for producing bioactive compounds.

Purpose of the Study:

  • To investigate the antifungal properties of a metabolite produced by Fusarium acuminatum NRRL 6227.
  • To characterize the mechanism of action of the antifungal metabolite on Penicillium species.
  • To identify the chemical nature of the antifungal compound.

Main Methods:

  • Incubation of Penicillium conidia with the Fusarium acuminatum metabolite.
  • Microscopic examination of conidia morphology and viability.
  • Assessment of resistance to osmotic shock.
  • Chemical analysis to determine the peptide composition.

Main Results:

  • The metabolite induced significant swelling (5-10 diameters) of Penicillium conidia.
  • Swollen conidia were nonviable, easily shattered, and inhibited from germination.
  • The antifungal compound was identified as a cyclic peptide containing alanine, glutamic acid, leucine, threonine, and tyrosine.

Conclusions:

  • Fusarium acuminatum NRRL 6227 produces a potent antifungal cyclic peptide.
  • This peptide effectively inhibits Penicillium germination by inducing lethal conidial swelling.
  • The identified cyclic peptide represents a potential lead for developing new antifungal therapies.

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...